首页> 外文期刊>Journal of Neuro-Oncology >Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?
【24h】

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

机译:使用灌注CT可以将通透性测量值添加到血容量测量值中,以区分高级别神经胶质瘤的肿瘤性脱髓鞘病变吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Tumefactive demyelinating lesions (TDLs) can mimic a neoplasm on conventional imaging and may necessitate biopsy for diagnosis. The purpose of this study was to differentiate TDLs from high grade gliomas based on physiologic (permeability) and hemodynamic (blood volume) parameters using perfusion CT. Five patients who presented with tumefactive enhancing lesions on initial MRI that mimicked a neoplasm underwent perfusion CT. We compared the perfusion CT parameters of these patients with those of 24 patients with high grade gliomas. TDLs showed lower permeability surface area product (PS) (0.8 ± 0.2 vs 2.4 ± 1.4 ml/100 g/min, P-value 0.014) and lower cerebral blood volume (CBV) (1.0 ± 0.2 vs 2.8 ± 1.2 ml/100 g, P-value 0.006) as compared to high grade gliomas. TDLs show lower PS and CBV as compared to high grade gliomas, to which they can mimic on conventional MR imaging, due to lack of neoangiogenesis and vascular endothelial proliferation and hence perfusion CT can be used to differentiate the two entities.
机译:Tumefactive脱髓鞘病变(TDL)可以模仿常规影像学上的肿瘤,可能需要进行活检以进行诊断。这项研究的目的是使用灌注CT根据生理学(通透性)和血液动力学(血液体积)参数来区分TDL和高级神经胶质瘤。五例在初次MRI上表现出肿瘤增生性病变并模仿肿瘤的患者接受了灌注CT检查。我们比较了这些患者和24例高级别胶质瘤患者的灌注CT参数。 TDL显示较低的通透性表面积积(PS)(0.8±0.2 vs 2.4±1.4 ml / 100 g / min,P值0.014)和较低的脑血容量(CBV)(1.0±0.2 vs 2.8±1.2 ml / 100 g ,P值0.006)与高级别神经胶质瘤相比。由于缺乏新生血管生成和血管内皮增生,TDLs与高级神经胶质瘤相比可以在常规MR成像上进行模拟,因此其PS和CBV更低,因此灌注CT可用于区分这两个实体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号